SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending following its third-quarter earnings report, where strong growth in AI semiconductor revenue—fueled by demand from major hyperscalers—initially drove a volatility-filled trading session. While investors reacted to fourth-quarter revenue guidance that fell slightly short of some high-end estimates, the conversation shifted to optimism after management provided a robust long-term outlook for fiscal 2027 and 2028.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Snowflake shares surged significantly after the company reported strong fiscal second-quarter financial results, highlighted by an earnings beat and an upward revision to its full-year product revenue outlook. The community reaction is sharply divided between bulls celebrating the accelerated AI-driven consumption of the company's data cloud tools and bears arguing that the stock's valuation is detached from its continued GAAP losses.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is trending as the community reacts to the upcoming presentation of new preclinical data for the drug SLS009 in pancreatic cancer at a major oncology conference. Investors remain focused on the potential of SLS009 alongside the ongoing Phase 3 trial for Galinpepimut-S, with discussions highlighting high conviction in the clinical pipeline despite ongoing volatility and debate regarding trial timelines.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell shares are trending following a strong quarterly earnings report that featured a significant upward revision to annual revenue guidance and a record AI server backlog, prompting a flurry of analyst price target hikes. While the community is overwhelmingly bullish on the AI infrastructure demand, many traders are actively debating the stock's high volatility and suspecting market manipulation due to rapid intraday price swings.

Hewlett Packard Enterprise Co. is a global edge-to-cloud company, which engages in the provision of information technology, technology and enterprise products, solutions, and services. It operates through the following segments: Server, Hybrid Cloud, Intelligent Edge, Financial Services, and Corporate Investments and Other. The Server segment consists of general-purpose servers for multi-workload computing and workload-optimized servers to deliver the performance and value for demanding applications, and integrated systems comprised of software and hardware designed to address high-performance computing and supercomputing, artificial intelligence, data analytics, and transaction processing workloads for government and commercial customers globally. The Hybrid Cloud segment is involved in a variety of cloud-native and hybrid solutions across storage, private cloud, and the infrastructure software-as-a-service space. The Intelligent Edge segment offers wired and wireless local area networks, campus, branch, and data center switching, software-defined wide-area-networks, private and public cellular network software, network security, and associated services that enable secure connectivity for businesses of any size. The Financial Services segment provides investment solutions, such as leasing, financing, IT consumption, utility programs, and asset management services for customers that facilitate technology deployment models and the acquisition of complete IT solutions, including hardware, software, and services from Hewlett Packard Enterprise and others. The Corporate Investments and Other segment includes the Advisory and Professional Services business, which primarily offers consultative-led services, HPE and partner technology expertise and advice, implementation services, as well as complex solution engagement capabilities, the Communications and Media Solutions business, which primarily offers software and related services to the telecommunications industry, and Hewlett Packard Labs, which is responsible for research and development. The company was founded by William R. Hewlett and David Packard on July 2, 1939 and is headquartered in Spring, TX.

Hewlett Packard Enterprise Co

Hewlett Packard Enterprise shares are receiving attention following a blowout fiscal third-quarter earnings report that saw the company beat analyst expectations for both revenue and earnings while raising its outlook. While the stock initially fell due to concerns regarding margin pressure and supply-chain constraints, many traders remain bullish, citing record revenue and strong demand in the AI infrastructure sector as long-term catalysts.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending amid ongoing market volatility and sector-wide weakness in data center stocks, with investors weighing the company's long-term growth potential and infrastructure expansion against concerns regarding high capital expenditures and macroeconomic pressures. While some traders express frustration with the recent share price decline and lack of immediate catalysts, others emphasize the company's strong contracted backlog and long-term business fundamentals as reasons to maintain a bullish outlook.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

Ultragenyx is trending following the failure of its Phase 3 Aspire study for apazunersen in Angelman syndrome to meet primary and secondary endpoints. The community reaction is sharply divided, with some investors focusing on the significant drop in market capitalization and potential for further downside, while others view the sell-off as an overreaction that creates a buying opportunity ahead of upcoming regulatory catalysts for the company's remaining gene therapy pipeline.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology shares fell sharply following quarterly earnings results, as investors reacted to concerns over gross margin compression and customer concentration risks despite a revenue beat. While some market participants express frustration over the volatility and potential market manipulation, others view the pullback as a buying opportunity, citing the company's strong long-term growth prospects in the AI infrastructure sector.

Fervo Energy Co. operates as a energy company. It builds and operates power facilities in extracting geothermal energy. The company was founded by Jack Norbeck and Timothy Latimer in 2017 and is headquartered in Berkeley, CA.

Fervo Energy Co. - Ordinary Shares - Class A

Fervo Energy Co

Fervo Energy is attracting significant attention following the announcement of a large power purchase agreement with Google to supply geothermal energy for potential data centers. While some traders view the deal as a major validation of the company's commercial scale and growth potential, others express skepticism regarding the company's profitability, high valuation, and reliance on future project developments.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Phoenix, AZ.

First Solar Inc

First Solar is experiencing downward price pressure and heightened volatility as traders weigh strong quarterly earnings and growth prospects against ongoing concerns regarding tariff policy uncertainty and general weakness in the solar sector. Community sentiment remains split between long-term investors viewing the stock as undervalued for its role in data center energy infrastructure and short-term traders reacting to technical sell-offs.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

12 Health Care Stocks Moving In Friday's Intraday Session

Gainers

Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 24.6% to $6.42 during Friday's regular session. The company's market cap stands at $10.3 million.
Aethlon Medical (NASDAQ:AEMD) shares moved upwards byread more...

12 Health Care Stocks Moving In Friday's Pre-Market Session

Gainers

Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 41.4% to $7.29 during Friday's pre-market session. The company's market cap stands at $10.3 million.
Aethlon Medical (NASDAQ:AEMD) stock moved upwards byread more...

12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers

Aethlon Medical (NASDAQ:AEMD) stock rose 50.7% to $3.27 during Thursday's after-market session. The market value of their outstanding shares is at $1.6 million.
Modular Medical (NASDAQ:MODD) stock roseread more...

Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier Program

Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier Program Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier Program PR Newswire SAN DIEGO, Aug. 13, 2026 Conference Call Today at 4:30 p.m. ETSAN DIEGO, Aug. 13, 2026 /PRNewswire/ -- Aethlon Medical...

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026 Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026 PR Newswire SAN DIEGO, Aug. 5, 2026 SAN DIEGO, Aug. 5, 2026 /PRNewswire/ -- Aethlon Medical...

Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier

Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier PR Newswire SAN DIEGO, July...

Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules

Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules PR Newswire SAN DIEGO, July 6, 2026 SAN DIEGO, July 6, 2026 /PRNewswire...

Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier

Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier PR Newswire SAN DIEGO, June 26...

Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update

Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update PR Newswire SAN DIEGO, June 10, 2026 Australian oncology study advances into Cohort 3 as enrollment...

The Next Meme Stock Wave?

A fresh wave of speculative activity swept through the small-cap market this week as traders piled into a combination of AI-linked companies, China-based growth stories, and emerging defense contractors. $BLIS, $GMM, $PAVS, $AEMD, $PAYO, $AZI, $CGTL, $CCSC, $ELPW, $JZXN, $MTEN

Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce on April 17, 1991 and is headquartered in San Diego, CA.

Feed

News

Sentiment

Earnings

Fundamentals

Info

AEMD Aethlon Medical Inc

Fundamentals

Latest AEMD News